Table 1.
LncRNA Name |
Splicing Target | Splicing Mechanism | Regulatory Effect or Associated Disease | Ref |
---|---|---|---|---|
LncRNAs regulating AS by chromatin modifications | ||||
asFGFR2 | FGFR2 | Recruiting Polycomb complexes and KDM2a to modify histone methylation and favor exon IIIb inclusion | Epithelial development | [23] |
Antisense transcripts at each Pcdhα first exon |
Pcdhα | First exon selection by histone modifications and distant DNA loop | Neuronal self-identity |
[31] |
LncRNAs regulate AS through DNA-RNA interactions | ||||
SEP3 exon6 circRNA (plant) |
SEP3 | Exon skipping through R-loop formation at exon 6 | Flowering time | [44] |
LncRNAs regulate AS through RNA-RNA interactions | ||||
NCYM NAT | NMYC | Intron I retention via antisense-sense RNA-RNA duplex |
Cancer | [57] |
NR1D1 | THRA | Favoring α1 isoform by forming antisense-sense RNA-RNA duplex with the α2 mRNA | Thyroid hormone-responsiveness | [58,59] |
SAF | FAS | Exon 6 skipping by forming RNA-RNA duplex with the target pre-mRNA and recruiting SPF45 | Cancer Apoptosis |
[60] |
ZEB2 NAT | ZEB2 | Preventing splicing of the IRES-containing intron through RNA-RNA interaction with the mRNA | EMT | [61] |
51A | SORL1 | Splicing shift from A to variant B by antisense-sense RNA-RNA duplex with an intronic sequence of the pre-mRNA | Alzheimer | [67] |
17A | GPR51 | Splicing shift from full-length to shorter GABAB R2 variant by antisense-sense RNA-RNA duplex | Alzheimer | [68] |
LncRNAs regulate AS by modulating the activity of splicing factors | ||||
MALAT1/NEAT2 | Modulation of SR localization and phosphorylation Uncoupling PTBP2 from SFPQ-PTBP2 |
Cancer | [73,88] | |
NEAT1 | PPARγ | By interacting with CLK1 kinase to modulate SRp40 phosphorylation status | Adipocyte differentiation | [71,89,90] |
Gomafu/RNCR2/
MIAT |
Interaction with QKI and SRSF1 Association with SF1 Localization of SF1 and Clf3 in CS bodies |
Schizophrenia Retinal cell and brain development Post-mitotic neuronal function |
[97,98,99,100] | |
LINC01133 | Interaction and titration of SRSF6 splicing factor from target genes | EMT | [101] | |
PNCTR | Hijacking PTBP1 in the perinucleolar compartment | Cell survival | [102] | |
TPM1-AS | TPM1 | Splicing shift to V1 or V3 isoforms by sequestering RBM4 | Cancer | [107] |
ASCO (plant) | Association with SmD1b and PRP8a and hijacking NSRa/b from the spliceosome | Lateral root formation | [109,110] | |
ENOD40 (plant) | Control nucleocytoplasmic of MtRBP1 | Symbiotic nodule development | [111,112] | |
PCGEM1 | Mutual bond with either hnRNP A1 or U2AF65 to promote or suppress specific AR splice variants | Castration resistance | [113] | |
BC200 | BCL-x | Interaction with pre-mRNA and recruitment of the hnRNP A2/B1 which prevent Sam68 association | Apoptosis | [115,117] |
Lnc-Spry1 | Interaction with U2AF65 | EMT | [118] | |
LASTR | Promoting splicing efficiency by interacting with SART3 | Stress-induced JNK/c-JUN pathway | [119] | |
LINC-HELLP | Interaction with ribosomal and splicing complex components (eg: YBX1, PCBP1, PCBP2, RPS6 and RPL7) | HELLP syndrome | [120] | |
DSCAM-AS1 | Exon skipping and 3′ UTR usage by interaction with hnRNPL | Tumor progression and anti-estrogen resistance | [121] | |
CircMbl | Mbl | Competing with the linear cognate by sequestering Mbl protein | Neuron Development | [123] |
CircSMARCA5 | Interaction with SRSF1 and promotion of the anti-angiogenic splicing isoforms of VEGF-A | Angiogenesis | [124] | |
PNUTS | PNUTS | Self-splicing regulation modulating the activity of hnRNP E1 | EMT | [126] |